[1] STUMVOLL M,TSCHRITTER O,FRITSCHE A,et al.Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity:interaction with family history of type 2 diabetes[J].Diabetes,2002,51(1):37-41.
[2] HUI X,LAIN K S,VANHOUTTE P M,et al.Adiponectin and cardiovascular health:an update[J].Br J Pharmaol,2012,165(3):574-590.
[3] WANNINGER J,NEUMEIER M,WEIGERT J,et al.Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2,p38MAPK,NF-kappaB,and STAT3 signaling pathways[J].Am J Physiol Gastrointest Liver Physiol,2009,297(3):G611-618.
[4] 顾晨,李俊明.脂联素在糖尿病心肌病发生发展中作用的研究进展[J].心血管病学进展,2012,33(5):657-660.
[5] 周婷婷,秦波,郑天鹏,等.非酒精性脂肪肝患者血浆FGF21水平及与肥胖、胰岛素抵抗关系研究[J].第三军医大学学报,2010,32(3):265-268.
[6] WEYER C,FUNAHASHI T,TANAKA S,et al.Hypoadiponectinemia in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinemia[J].J Clin Endoerinol Metab,2001,86(5):1930-1935.
[7] 杨玲,袁国跃,王东,等.2型糖尿病患者血清Vaspin水平的变化及其临床意义[J].中国综合临床,2011,27(2):125-127.
[8] HOLST J J,BINDERUP M.Fatty tissue and insulin resistance and adiponectin [J].Ugeslkr Laeger,2002,164(16):2173-2176.
[9] 王宏,王文宏.脂联素与脑卒中关系研究进展[J].东南大学学报:医学版,2012,31(2):235-238.
[10] VOULGRI C,PAPADOGIANS D,TENTOLOURIS N.Diabetic cardiomyopathy:from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies[J].Vasc Health Risk Manag,2010,6:883-903.
[11] 宋光远,吴永健.糖尿病心肌病存在和机制[J].心血管病学进展,2011,32(4):493-498.
[12] MOTOZHIMA H,WU X,MABADEV K,et al.Adiponectin suppresses proliferation a superoxide generation and enhances eNOS acdvity in endothelial cells treated oxidized LDL[J].Bioehem Biophys Res Commun,2004,315(2):264-271.
[13] LI P,SHIBATA R,UNNO K,et al.Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone[J].Hypertension,2010,55(1):69-75.
[14] TAO L,WANG Y,GAO E,et al.Adiponectin:an indispensable molecule in rosiglitazone cardioprotective following myocardial infarction[J].Circ Res,2010,106(2):409-417.
[15] SHIMANO M,OUCHI N,SHIBATA R,et al.Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response[J].J Mol Cell Cardiol,2010,49(2):210-220.
[16] KONDO K,SHIBATA R,UNNO K,et al.Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model[J].Circ Cardiovasc Interv,2010,3(2):166-173.
[17] TURER A T,BROWNING J D,AYERS C R,et al.Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study[J].J Clin Endocrinol Metab,2012,97(6):E982-986.
[18] HOTTA K,FUNAHASHI T,ARITA Y,et al.Plasma concentrations of a novel,adipose-specific protein,adiponectin,in type 2 diabetic patients[J].Arterioscler Thromb Vasc Biol,2000,20(6):1595-1599.
[19] 许轶洲,高炎.脂联素与心血管疾病[J].生命科学,2010,22(4):313-315.
[20] 周桂建,张宁汝,张恒,等.内脂素与冠心病关系的探讨[J].中国综合临床,2011,27(4):384-386.
[21] ZAMPETAKI A,KIRTON J P,XU Q.Vascular repair by endothelial progenitor cells[J].Cardiovasc Res,2008,78(3):413-421.
[22] SHIBATA R,SKURK C,OUCHI N,et al.Adiponectin promotes endothelial progenitor cell number and function[J].FEBS Lett,2008,582(11):1607-1612.
[23] SAMBUCETI G,MORBELLI S,VANELLA L,et al.Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage,reversed by increases in pAMPK,heme oxygenase-1,and adiponectin[J].Stem Cell,2009,27:399-407.
[24] LIBBY P,OKAMOTO Y,ROCHA V Z,et al.Inflammation in atherosclerosis: transition from theory to practice[J].Circ J,2010,74:213-220.
[25] FAN D,LI L,WANG C,et al.Adiponectin induces interleukin-6 production and its underlying mechanism in adult rat cardiac fibroblasts[J].J Cell Physiol,2011,226(7):1793-1802.
[26] CHENG X,FOLCO E J,SHIMIZU K,et al.Adiponectin induces pro-inflammatory programs in human macrophages and CD4+T cells[J].J Biol Chem,2012,287(44):36896-36904.
[27] 刘显庆.特殊的心血管保护性脂肪因子-脂联素[J].国外医学心血管疾病分册,2005,322(2):77-79.
[28] 冯燕娴,石增刚,汤凤英,等.血清载脂蛋白B、载脂蛋白B/载脂蛋白A1值与冠状动脉病变的相关性分析[J].东南大学学报:医学版,2011,30(4):577-580.
[29] 何爱琴,吴小梅,缪珩.2型糖尿病患者ApoA1/ApoB之值与其血管并发症关系分析[J].现代医学,2012,40(5):556-559.
[30] LINCOFF A M,WOLSKI K,NICHOLLS S J,et al.Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus:a meta-analysis of randomized trials[J].JAMA,2007,298(10):1180-1188.
[31] PHILLIPS S A,KUNG J,CIARALDI T P,et al.Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans[J].Am J Physiol Endocrinol Metab,2009,297(3):E767-73.
[32] WANG Z V,SCHERER P E.Adiponectin,cardiovascular function,and hypertension[J].Hypertension,2008,51(1):8-14.
[33] TISHINSKY J M,DYCK D J,ROBINSON L E.Lifestyle factors increasing adiponectin synthesis and secretion[J].Vitam Horm,2012,90:1-30. |
